Pfizer to end heart, obesity drug development - Tidingo.com

Pfizer to end heart, obesity drug development

Link:

Pfizer Inc will drop efforts to develop medicines for heart disease, obesity and bone health as part of its plan to focus research on cancer and five other therapeutic areas, a company memo showed.

Pfizer to end heart, obesity drug development - témata

Pfizer, Inc, Pfizer Inc, Pfizer to end heart, obesity drug development,

Podobné zprávy

RSS sources

Your own sources

Your own RSS you can add after registration

Public sources


Create an account Password
© 2005-2008  
RSS Sources list
Loading messages